SCHEMBL28073639

SCHEMBL28073639

C=C(N)C(=O)Oc1ccc(OC)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 5/20 0.53
CA2 P00918 5/20 0.53
PARP10 Q53GL7 2/20 0.53
PARP1 P09874 1/20 0.53
PARP2 Q9UGN5 1/20 0.53
PARP4 Q9UKK3 1/20 0.53
MAPT P10636 1/20 0.48
SMN1; SMN2 Q16637 3/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
CES2 O00748 1/20 0.47
CES1 P23141 1/20 0.47
PRSS1 P07477 2/20 0.46
ACR P10323 1/20 0.46
TGM2 P21980 1/20 0.44
LMNA P02545 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
CA12 O43570 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28103049 0.84 ALDH1A1 (0.44) CA1CA2PARP10PARP1PARP2
SCHEMBL28213866 0.83 CA1 (0.57) CA1CA2PARP10PARP1PARP2
SCHEMBL7061292 0.83 CES2 (0.58) CA1CA2PARP10PARP1PARP2
SCHEMBL28097763 0.82 PARP1 (0.54) PARP1CES2CES1PRSS1ACR
SCHEMBL28103050 0.82 CA12 (0.52) CA1CA2MAPTSMN1; SMN2NPC1
SCHEMBL450454 0.82 ELANE (0.61) CA1CA2PARP10PARP1PARP2
SCHEMBL28833766 0.79 MAPT (0.51) CA1CA2MAPTSMN1; SMN2NPC1
SCHEMBL28097833 0.79 PRSS1 (0.50) CA1CA2MAPTSMN1; SMN2NPC1
SCHEMBL28097757 0.79 RAB9A (0.47) SMN1; SMN2NPC1RAB9ALMNACYP2C19
SCHEMBL27505259 0.79 ELANE (0.49) PARP10MAPTPRSS1ACRPRSS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103664974-B Aryl [a] indole [2,3-g] quinolizine compounds, its preparation method, pharmaceutical composition and application thereof 中国科学院上海药物研究所 2016-12-21 CN disclosed
CN-103917094-B Glucosylceramide Synthase Inhibitors 建新公司 2016-11-09 CN disclosed
CN-105899508-A Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection 豪夫迈·罗氏有限公司 2016-08-24 CN disclosed
CN-105712812-A Chiral beta-arylamine compounds prepared by asymmetric reductive amination reaction and preparation method of chiral beta-arylamine compounds 西北农林科技大学 2016-06-29 CN disclosed